Antimycobacterial Therapy in Crohn's Disease: Results of a Controlled, Double‐Blind Trial with a Multiple Antibiotic Regimen

The American Journal of Gastroenterology

Volumn 89, Issue 4, 1994, Pages 513-518

  Prantera, C ^a   Kohn, Anna ^a   Mangiarotti, R ^a   Andreoli, A ^a   Luzi, C ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CLOFAZIMINE; DAPSONE; ETHAMBUTOL; PLACEBO; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; MALE; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION;

ADULT; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CLOFAZIMINE; CROHN DISEASE; DAPSONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; PROSPECTIVE STUDIES; RIFAMPIN; TIME FACTORS;

EID: 0028197568     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1994.tb07909.x     Document Type: Article

References (29)

1. Mycobacteria as a possible cause of inflammatory bowel disease
2. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified mycobacterium species isolated from patients with Crohn's disease
3. Preliminary report on isolation of mycobacteria from patients with Crohn's disease
4. Mycobacteria and inflammatory bowel disease. Results of culture
5. Serum antibodies to mycobacterial antigens in active Crohn's disease
6. Investigation of mycobacteria in Crohn's disease tissue by Southern blotting and DNA hybridisation with cloned mycobacterial genomic DNA probes from a Crohn's disease isolated mycobacteria
7. Dapsone in Crohn's disease
8. Remission of Crohn's disease with tuberculosis chemotherapy
9. Crohn's disease and mycobacteria: Two cases of Crohn's disease with high anti‐mycobacterial antibody levels cured by dapsone therapy
10. Combination antimycobacterial chemotherapy with major clinical response in established Crohn's disease
11. Controlled trial of rifampicin and ethambutol in Crohn's disease
12. Crohn's disease: Entity and aetiopathogenic concepts
13. Mycobacteria and subgroups of patients in Crohn's disease
14. Pulmonary infection with Mycobacterium kansasii in Wales 1970–9: Review of treatment and response
15. Disease due to Mycobacterium avium‐intracellulare
16. Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo
17. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
18. Leprosy
19. Response of tuberculous stricture to antituberculous treatment
20. Clinical, biological, and endoscopic picture of attacks of Crohn's disease
21. Glucocorticoid treatment in ileal Crohn's disease: Relief of symptoms but not of endoscopically viewed inflammation
22. Lung disease caused by Mycobacterium avium/Mycobacterium intracellulare
23. Ruminant paratuberculosis (Johne's disease): The current status and future prospects
24. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease
25. Radiologic and clinical assessment of broad‐spectrum antibiotic therapy in Crohn's disease
26. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: The cooperative Crohn's disease study in Sweden. Result
27. Treatment of Crohn's disease complication with ciprofloxacin
28. Controlled trial comparing prednisolone with an elemental diet plus non‐absorbable antibiotics in active Crohn's disease